Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Surgical management of gastroesophageal reflux in adults

Steven D Schwaitzberg, MD, FACS
Section Editors
Joseph S Friedberg, MD
Nicholas J Talley, MD, PhD
Deputy Editor
Wenliang Chen, MD, PhD


Surgical management is generally reserved for patients with complications of reflux such as recurrent or refractory esophagitis, stricture, Barrett's metaplasia, persistent "reflux symptoms" despite acid suppression, or asthma. Patients who are unable to tolerate medication, noncompliant with medication, or who are medication dependent and unwilling to take lifelong medications are also surgical candidates.

The surgical management of patients with gastroesophageal reflux disease (GERD) is reviewed in this topic. The pathophysiology, diagnosis, medical management, and complications of gastroesophageal reflux are discussed elsewhere. (See "Pathophysiology of reflux esophagitis" and "Medical management of gastroesophageal reflux disease in adults" and "Complications of gastroesophageal reflux in adults" and "Overview of gastrointestinal motility testing", section on 'Esophagus'.)


There are several indications for surgery in the patient with GERD:

Gastrointestinal indications

Failed optimal medical management

Noncompliance with medical therapy

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Oct 02, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Zaninotto G, Attwood SE. Surgical management of refractory gastro-oesophageal reflux. Br J Surg 2010; 97:139.
  2. Downing TE, Sporn TA, Bollinger RR, et al. Pulmonary histopathology in an experimental model of chronic aspiration is independent of acidity. Exp Biol Med (Maywood) 2008; 233:1202.
  3. Lazarchik DA, Frazier KB. Dental erosion and acid reflux disease: an overview. Gen Dent 2009; 57:151.
  4. Johnson WE, Hagen JA, DeMeester TR, et al. Outcome of respiratory symptoms after antireflux surgery on patients with gastroesophageal reflux disease. Arch Surg 1996; 131:489.
  5. Johanson JF. Epidemiology of esophageal and supraesophageal reflux injuries. Am J Med 2000; 108 Suppl 4a:99S.
  6. Jindal JR, Milbrath MM, Shaker R, et al. Gastroesophageal reflux disease as a likely cause of "idiopathic" subglottic stenosis. Ann Otol Rhinol Laryngol 1994; 103:186.
  7. Smullen JL, Lejeune FE Jr. Otolaryngologic manifestations of gastroesophageal reflux disease. J La State Med Soc 1999; 151:115.
  8. Nostrant TT. Gastroesophageal reflux and laryngitis: a skeptic's view. Am J Med 2000; 108 Suppl 4a:149S.
  9. Ormseth EJ, Wong RK. Reflux laryngitis: pathophysiology, diagnosis, and management. Am J Gastroenterol 1999; 94:2812.
  10. Ulualp SO, Toohill RJ, Shaker R. Outcomes of acid suppressive therapy in patients with posterior laryngitis. Otolaryngol Head Neck Surg 2001; 124:16.
  11. Hanson DG, Jiang JJ. Diagnosis and management of chronic laryngitis associated with reflux. Am J Med 2000; 108 Suppl 4a:112S.
  12. Hanson DG, Conley D, Jiang J, Kahrilas P. Role of esophageal pH recording in management of chronic laryngitis: an overview. Ann Otol Rhinol Laryngol Suppl 2000; 184:4.
  13. Fraser AG, Morton RP, Gillibrand J. Presumed laryngo-pharyngeal reflux: investigate or treat? J Laryngol Otol 2000; 114:441.
  14. El-Serag HB, Lee P, Buchner A, et al. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol 2001; 96:979.
  15. Kamel PL, Hanson D, Kahrilas PJ. Omeprazole for the treatment of posterior laryngitis. Am J Med 1994; 96:321.
  16. Hinder RA, Branton SA, Floch NR. Surgical therapy for supraesophageal reflux complications of gastroesophageal reflux disease. Am J Med 2000; 108 Suppl 4a:178S.
  17. Farrell TM, Richardson WS, Trus TL, et al. Response of atypical symptoms of gastro-oesophageal reflux to antireflux surgery. Br J Surg 2001; 88:1649.
  18. Swoger J, Ponsky J, Hicks DM, et al. Surgical fundoplication in laryngopharyngeal reflux unresponsive to aggressive acid suppression: a controlled study. Clin Gastroenterol Hepatol 2006; 4:433.
  19. Kaufman JA, Houghland JE, Quiroga E, et al. Long-term outcomes of laparoscopic antireflux surgery for gastroesophageal reflux disease (GERD)-related airway disorder. Surg Endosc 2006; 20:1824.
  20. Field SK, Gelfand GA, McFadden SD. The effects of antireflux surgery on asthmatics with gastroesophageal reflux. Chest 1999; 116:766.
  21. Spivak H, Smith CD, Phichith A, et al. Asthma and gastroesophageal reflux: fundoplication decreases need for systemic corticosteroids. J Gastrointest Surg 1999; 3:477.
  22. Field SK, Sutherland LR. Does medical antireflux therapy improve asthma in asthmatics with gastroesophageal reflux?: a critical review of the literature. Chest 1998; 114:275.
  23. Spechler SJ, Gordon DW, Cohen J, et al. The effects of antireflux therapy on pulmonary function in patients with severe gastroesophageal reflux disease. Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. Am J Gastroenterol 1995; 90:915.
  24. Sontag SJ, O'Connell S, Khandelwal S, et al. Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies. Am J Gastroenterol 2003; 98:987.
  25. Fibbe C, Layer P, Keller J, et al. Esophageal motility in reflux disease before and after fundoplication: a prospective, randomized, clinical, and manometric study. Gastroenterology 2001; 121:5.
  26. Kauer WK, Peters JH, DeMeester TR, et al. A tailored approach to antireflux surgery. J Thorac Cardiovasc Surg 1995; 110:141.
  27. Singhal V, Khaitan L. Preoperative evaluation of gastroesophageal reflux disease. Surg Clin North Am 2015; 95:615.
  28. Mikami DJ, Murayama KM. Physiology and pathogenesis of gastroesophageal reflux disease. Surg Clin North Am 2015; 95:515.
  29. Ip S, Tatsioni A, Conant A, et al. Predictors of clinical outcomes following fundoplication for gastroesophageal reflux disease remain insufficiently defined: a systematic review. Am J Gastroenterol 2009; 104:752.
  30. Ludemann R, Watson DI, Jamieson GG, et al. Five-year follow-up of a randomized clinical trial of laparoscopic total versus anterior 180 degrees fundoplication. Br J Surg 2005; 92:240.
  31. Peters MJ, Mukhtar A, Yunus RM, et al. Meta-analysis of randomized clinical trials comparing open and laparoscopic anti-reflux surgery. Am J Gastroenterol 2009; 104:1548.
  32. Niebisch S, Fleming FJ, Galey KM, et al. Perioperative risk of laparoscopic fundoplication: safer than previously reported-analysis of the American College of Surgeons National Surgical Quality Improvement Program 2005 to 2009. J Am Coll Surg 2012; 215:61.
  33. Oor JE, Roks DJ, Broeders JA, et al. Seventeen-year Outcome of a Randomized Clinical Trial Comparing Laparoscopic and Conventional Nissen Fundoplication: A Plea for Patient Counseling and Clarification. Ann Surg 2017; 266:23.
  34. Morino M, Pellegrino L, Giaccone C, et al. Randomized clinical trial of robot-assisted versus laparoscopic Nissen fundoplication. Br J Surg 2006; 93:553.
  35. Stein HJ, Bremner RM, Jamieson J, DeMeester TR. Effect of Nissen fundoplication on esophageal motor function. Arch Surg 1992; 127:788.
  36. Peters JH, DeMeester TR. Esophagus and diaphragmatic hernia. In: Principles of Surgery, Schwartz, SI, Shires, GT, Spencer, FC (Eds), McGraw-Hill, New York 1994. p.1043.
  37. Ellis FH Jr. The Nissen fundoplication. Ann Thorac Surg 1992; 54:1231.
  38. Kraemer SJ, Aye R, Kozarek RA, Hill LD. Laparoscopic Hill repair. Gastrointest Endosc 1994; 40:155.
  39. Patti MG, Goldberg HI, Arcerito M, et al. Hiatal hernia size affects lower esophageal sphincter function, esophageal acid exposure, and the degree of mucosal injury. Am J Surg 1996; 171:182.
  40. Stein HJ, Feussner H, Siewert JR. Failure of antireflux surgery: causes and management strategies. Am J Surg 1996; 171:36.
  41. Gott JP, Polk HC Jr. Repeat operation for failure of antireflux procedures. Surg Clin North Am 1991; 71:13.
  42. Granderath FA, Kamolz T, Schweiger UM, et al. Long-term results of laparoscopic antireflux surgery. Surg Endosc 2002; 16:753.
  43. Lundell L, Miettinen P, Myrvold HE, et al. Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease. J Am Coll Surg 2001; 192:172.
  44. Spechler SJ, Lee E, Ahnen D, et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA 2001; 285:2331.
  45. Mahon D, Rhodes M, Decadt B, et al. Randomized clinical trial of laparoscopic Nissen fundoplication compared with proton-pump inhibitors for treatment of chronic gastro-oesophageal reflux. Br J Surg 2005; 92:695.
  46. Stein HJ, DeMeester TR. Who benefits from antireflux surgery? World J Surg 1992; 16:313.
  47. Hinder RA, Filipi CJ, Wetscher G, et al. Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg 1994; 220:472.
  48. Trus TL, Laycock WS, Branum G, et al. Intermediate follow-up of laparoscopic antireflux surgery. Am J Surg 1996; 171:32.
  49. Peters JH, Heimbucher J, Kauer WK, et al. Clinical and physiologic comparison of laparoscopic and open Nissen fundoplication. J Am Coll Surg 1995; 180:385.
  50. Rattner DW, Brooks DC. Patient satisfaction following laparoscopic and open antireflux surgery. Arch Surg 1995; 130:289.
  51. Nilsson G, Wenner J, Larsson S, Johnsson F. Randomized clinical trial of laparoscopic versus open fundoplication for gastro-oesophageal reflux. Br J Surg 2004; 91:552.
  52. Rice S, Watson DI, Lally CJ, et al. Laparoscopic anterior 180 degrees partial fundoplication: five-year results and beyond. Arch Surg 2006; 141:271.
  53. McKenzie D, Grayson T, Polk HC Jr. The impact of omeprazole and laparoscopy upon hiatal hernia and reflux esophagitis. J Am Coll Surg 1996; 183:413.
  54. Salminen PT, Hiekkanen HI, Rantala AP, Ovaska JT. Comparison of long-term outcome of laparoscopic and conventional nissen fundoplication: a prospective randomized study with an 11-year follow-up. Ann Surg 2007; 246:201.
  55. Ip S, Bonis P, Tatsioni A, et a. Comparative Effectiveness of Management Strategies for Gastroesophageal Reflux Disease. Evidence Report/Technology Assessment No. 1. (Prepared by Tufts-New England Medical Center. Evidence-based Practice Center under Contract No. 290-02-0022.) Rockville, MD: Agency for Healthcare Research and Quality. December 2005. www.effectivehealthcare.ahrq.gov/reports/final.cfm (Accessed on December 18, 2007).
  56. Spechler SJ. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. N Engl J Med 1992; 326:786.
  57. Bais JE, Bartelsman JF, Bonjer HJ, et al. Laparoscopic or conventional Nissen fundoplication for gastro-oesophageal reflux disease: randomised clinical trial. The Netherlands Antireflux Surgery Study Group. Lancet 2000; 355:170.
  58. Klaus A, Hinder RA, DeVault KR, Achem SR. Bowel dysfunction after laparoscopic antireflux surgery: incidence, severity, and clinical course. Am J Med 2003; 114:6.
  59. Hunter JG, Swanstrom L, Waring JP. Dysphagia after laparoscopic antireflux surgery. The impact of operative technique. Ann Surg 1996; 224:51.
  60. Herron DM, Swanström LL, Ramzi N, Hansen PD. Factors predictive of dysphagia after laparoscopic Nissen fundoplication. Surg Endosc 1999; 13:1180.
  61. Watson DI, Baigrie RJ, Jamieson GG. A learning curve for laparoscopic fundoplication. Definable, avoidable, or a waste of time? Ann Surg 1996; 224:198.
  62. Harris SC. Laparoscopic antireflux surgery. Am J Surg 1996; 171:482.
  63. Cartlidge CW, Stewart GD, de Beaux AC, Paterson-Brown S. The evolution of laparoscopic antireflux surgery and its influence on postoperative stay. Scott Med J 2011; 56:64.
  64. Roks DJ, Koetje JH, Oor JE, et al. Randomized clinical trial of 270° posterior versus 180° anterior partial laparoscopic fundoplication for gastro-oesophageal reflux disease. Br J Surg 2017; 104:843.
  65. Little AG. Mechanisms of action of antireflux surgery: theory and fact. World J Surg 1992; 16:320.
  66. Orlando RC. Reflux esophagitis. In: Textbook of Gastroenterology, Yamada, T (Eds), JB Lippincott Company, Philadelphia 1995. p.1214.
  67. Csendes A, Burgos AM, Smok G, et al. Effect of gastric bypass on Barrett's esophagus and intestinal metaplasia of the cardia in patients with morbid obesity. J Gastrointest Surg 2006; 10:259.
  68. Houghton SG, Romero Y, Sarr MG. Effect of Roux-en-Y gastric bypass in obese patients with Barrett's esophagus: attempts to eliminate duodenogastric reflux. Surg Obes Relat Dis 2008; 4:1.
  69. Cobey F, Oelschlager B. Complete regression of Barrett's esophagus after Roux-en-Y gastric bypass. Obes Surg 2005; 15:710.
  70. Kmiot WA, Kirby RM, Akinola D, Temple JG. Prospective randomized trial of Nissen fundoplication and Angelchik prosthesis in the surgical treatment of medically refractory gastro-oesophageal reflux disease. Br J Surg 1991; 78:1181.
  71. Warren HF, Louie BE, Farivar AS, et al. Manometric Changes to the Lower Esophageal Sphincter After Magnetic Sphincter Augmentation in Patients With Chronic Gastroesophageal Reflux Disease. Ann Surg 2017; 266:99.
  72. Ganz RA, Edmundowicz SA, Taiganides PA, et al. Long-term Outcomes of Patients Receiving a Magnetic Sphincter Augmentation Device for Gastroesophageal Reflux. Clin Gastroenterol Hepatol 2016; 14:671.
  73. Lipham JC, DeMeester TR, Ganz RA, et al. The LINX® reflux management system: confirmed safety and efficacy now at 4 years. Surg Endosc 2012; 26:2944.
  74. Bonavina L, DeMeester T, Fockens P, et al. Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one- and 2-year results of a feasibility trial. Ann Surg 2010; 252:857.
  75. Jafri SM, Arora G, Triadafilopoulos G. What is left of the endoscopic antireflux devices? Curr Opin Gastroenterol 2009; 25:352.
  76. Dughera L, Rotondano G, De Cento M, et al. Durability of Stretta Radiofrequency Treatment for GERD: Results of an 8-Year Follow-Up. Gastroenterol Res Pract 2014; 2014:531907.
  77. Funk LM, Zhang JY, Drosdeck JM, et al. Long-term cost-effectiveness of medical, endoscopic and surgical management of gastroesophageal reflux disease. Surgery 2015; 157:126.
  78. Liang WT, Yan C, Wang ZG, et al. Early and Midterm Outcome After Laparoscopic Fundoplication and a Minimally Invasive Endoscopic Procedure in Patients with Gastroesophageal Reflux Disease: A Prospective Observational Study. J Laparoendosc Adv Surg Tech A 2015; 25:657.
  79. Yan C, Liang WT, Wang ZG, et al. Comparison of Stretta procedure and toupet fundoplication for gastroesophageal reflux disease-related extra-esophageal symptoms. World J Gastroenterol 2015; 21:12882.
  80. http://www.sages.org/publications/guidelines/endoluminal-treatments-for-gastroesophageal-reflux-disease-gerd/ (Accessed on July 15, 2013).
  81. Dominitz JA, Dire CA, Billingsley KG, Todd-Stenberg JA. Complications and antireflux medication use after antireflux surgery. Clin Gastroenterol Hepatol 2006; 4:299.
  82. Malhi-Chowla N, Gorecki P, Bammer T, et al. Dilation after fundoplication: timing, frequency, indications, and outcome. Gastrointest Endosc 2002; 55:219.
  83. Boddy AP, Mehta S, Bennett J, et al. Postoperative esophageal physiology studies may help to predict long-term symptoms following laparoscopic Nissen fundoplication. Surg Endosc 2008; 22:1298.
  84. Lord RV, Kaminski A, Oberg S, et al. Absence of gastroesophageal reflux disease in a majority of patients taking acid suppression medications after Nissen fundoplication. J Gastrointest Surg 2002; 6:3.
  85. Kalinowska E, Tarnowski W, Bielecki K, Banasiewicz J. Quality of life before and after laparoscopic fundoplication. Does quality of life depend on psychological factors? Preliminary report. Wiad Lek 2006; 59:772.
  86. Granderath FA, Kamolz T, Granderath UM, Pointner R. Gas-related symptoms after laparoscopic 360 degrees Nissen or 270 degrees Toupet fundoplication in gastrooesophageal reflux disease patients with aerophagia as comorbidity. Dig Liver Dis 2007; 39:312.
  87. De Vault K. Gas bloat syndrome: a pre- or postoperative dysmotility syndrome? Am J Gastroenterol 1995; 90:1536.
  88. Masqusi S, Velanovich V. Pyloroplasty with fundoplication in the treatment of combined gastroesophageal reflux disease and bloating. World J Surg 2007; 31:332.
  89. Nguyen NT, Dholakia C, Nguyen XM, Reavis K. Outcomes of minimally invasive esophagectomy without pyloroplasty: analysis of 109 cases. Am Surg 2010; 76:1135.
  90. Lamb PJ, Myers JC, Jamieson GG, et al. Long-term outcomes of revisional surgery following laparoscopic fundoplication. Br J Surg 2009; 96:391.
  91. Dassinger MS, Torquati A, Houston HL, et al. Laparoscopic fundoplication: 5-year follow-up. Am Surg 2004; 70:691.
  92. Cowgill SM, Arnaoutakis D, Villadolid D, et al. Results after laparoscopic fundoplication: does age matter? Am Surg 2006; 72:778.
  93. Maret-Ouda J, Wahlin K, El-Serag HB, Lagergren J. Association Between Laparoscopic Antireflux Surgery and Recurrence of Gastroesophageal Reflux. JAMA 2017; 318:939.
  94. Mardani J, Lundell L, Engström C. Total or posterior partial fundoplication in the treatment of GERD: results of a randomized trial after 2 decades of follow-up. Ann Surg 2011; 253:875.
  95. Broeders JA, Roks DJ, Ahmed Ali U, et al. Laparoscopic anterior 180-degree versus nissen fundoplication for gastroesophageal reflux disease: systematic review and meta-analysis of randomized clinical trials. Ann Surg 2013; 257:850.
  96. Nijjar RS, Watson DI, Jamieson GG, et al. Five-year follow-up of a multicenter, double-blind randomized clinical trial of laparoscopic Nissen vs anterior 90 degrees partial fundoplication. Arch Surg 2010; 145:552.
  97. Khan M, Smythe A, Globe J, et al. Randomized controlled trial of laparoscopic anterior versus posterior fundoplication for gastro-oesophageal reflux disease. ANZ J Surg 2010; 80:500.
  98. Watson DI, Jamieson GG, Pike GK, et al. Prospective randomized double-blind trial between laparoscopic Nissen fundoplication and anterior partial fundoplication. Br J Surg 1999; 86:123.
  99. Engström C, Lönroth H, Mardani J, Lundell L. An anterior or posterior approach to partial fundoplication? Long-term results of a randomized trial. World J Surg 2007; 31:1221.
  100. Broeders JA, Roks DJ, Ahmed Ali U, et al. Laparoscopic anterior versus posterior fundoplication for gastroesophageal reflux disease: systematic review and meta-analysis of randomized clinical trials. Ann Surg 2011; 254:39.
  101. Galmiche JP, Hatlebakk J, Attwood S, et al. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA 2011; 305:1969.
  102. Grant AM, Wileman SM, Ramsay CR, et al. Minimal access surgery compared with medical management for chronic gastro-oesophageal reflux disease: UK collaborative randomised trial. BMJ 2008; 337:a2664.
  103. Grant AM, Cotton SC, Boachie C, et al. Minimal access surgery compared with medical management for gastro-oesophageal reflux disease: five year follow-up of a randomised controlled trial (REFLUX). BMJ 2013; 346:f1908.
  104. Garg SK, Gurusamy KS. Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adults. Cochrane Database Syst Rev 2015; :CD003243.
  105. Hatlebakk JG, Zerbib F, Bruley des Varannes S, et al. Gastroesophageal Acid Reflux Control 5 Years After Antireflux Surgery, Compared With Long-term Esomeprazole Therapy. Clin Gastroenterol Hepatol 2016; 14:678.